Localized Wegener's granulomatosis: Predominance of CD26 and IFN-γ expression

Journal of Pathology

Volumn 192, Issue 1, 2000, Pages 113-120

  Müller, Antje ^a   Trabandt, Andreas ^a   Gloeckner Hofmann, Katharina ^a   Seitzer, Ulrike ^b   Csernok, Elena ^a   Schönermarck, Ulf ^a   Feller, Alfred C ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

CD26; Granuloma; IFN ; Localized Wegener's granulomatosis

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD26; BIOPSY; CELL CULTURE TECHNIQUES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MALE; MIDDLE AGED; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WEGENER GRANULOMATOSIS;

EID: 0033828445     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH656>3.0.CO;2-M     Document Type: Article

References (37)

1. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis
2. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)
3. Case 28-1998
4. The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis
5. 50 Jahre Wegenersche Granulomatosc
6. Pulmonary vasculitis
7. Wegener's granulomatosis
8. Subject review/treatment of antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
9. Pathogenesis of Wegener's granulomatosis
10. Activated CD4+ and CD8+ T cell subsets in Wegener's granulomatosis
11. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis
12. Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells
13. T cell cytokine profiles in patients with Wegener's granulomatosis
14. Cytokine profiles in Wegener's granulomatosis: Predominance of type-1 (Th1) in the granulomatous inflammation
15. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: Reversal with IL-10
16. IFN-γ differentially regulates IL-12 and IL-10 production in leprosy
17. Molecules associated with human Th1 or Th2 cells
18. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis
19. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis
20. Illustrated histopathological classification criteria for selected vasculitis syndromes
21. CD26 expression in leprosy and other granulomatous diseases correlates with the production of IFN-γ
22. A new anti-K1 (CD30) monoclonal antibody directed at a formol-resistant epitope
23. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes
24. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy
25. Pleiotropic biologic functions of CD30/CD30L
26. Wegener's granulomatosis. Anatomic correlates, a proposed classification
27. Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis
28. In situ production of TNFα, IL-lβ and IL-2R in ANCA-positive glomerulonephritis
29. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation, cytokine production
30. IL-12 primes human CD4 and CD8 T cell clones for high production of both IFN-γ and IL-10
31. Identification of a T cell subset capable of both IFN-γ and IL-10 secretion in patients with chronic Borrelia burgdorferi infection
32. Rheumatoid inflammatory T cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns
33. A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis
34. IL-10 deficient mice develop chronic enterocolitis
35. Dysregulation of IL-10 production in relatives of patients with systemic lupus erythematosus
36. Effects of intravenous immunoglobulin on plasma IL-10 levels in Kawasaki disease
37. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis